StockData
Surgery Partners, Inc. logo

Surgery Partners, Inc. (SGRY) stock

SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3021% above fair value
$26.69−0.27 (-1.00%)

Close on Nov 19, 2026Market cap $3.49BP/E –Yield –

Surgery Partners free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Surgery Partners's free cash flow for the twelve months ending Jun 30, 2026 was $187.60M, up 7.0% year over year. For fiscal 2025 it was $195.60M, down 6.7% from the year before. Over ten years it grew 30.0% a year on average. The highest annual figure on record is $209.70M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$195.60M-6.7%
FY2024Dec 31, 2024$209.70M+2.3%
FY2023Dec 31, 2023$205.00M+162.1%
FY2022Dec 31, 2022$78.20M+165.1%
FY2021Dec 31, 2021$29.50M-85.5%
FY2020Dec 31, 2020$204.00M+264.9%
FY2019Dec 31, 2019$55.90M-46.7%
FY2018Dec 31, 2018$104.80M+21.7%
FY2016Dec 31, 2016$86.13M+68.7%
FY2015Dec 31, 2015$51.04M+259.1%
FY2014Dec 31, 2014$14.21M-68.4%
FY2013Dec 31, 2013$44.93M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$37.50M-35.2%
Q1 FY2026Mar 31, 2026-$4.30M–
Q4 FY2025Dec 31, 2025$90.60M+1.7%
Q3 FY2025Sep 30, 2025$63.80M+41.8%
Q2 FY2025Jun 30, 2025$57.90M+3.6%
Q1 FY2025Mar 31, 2025-$16.70M-184.8%
Q4 FY2024Dec 31, 2024$89.10M+108.2%
Q3 FY2024Sep 30, 2024$45.00M-47.5%
Q2 FY2024Jun 30, 2024$55.90M+112.5%
Q1 FY2024Mar 31, 2024$19.70M-60.8%
Q4 FY2023Dec 31, 2023$42.80M–
Q3 FY2023Sep 30, 2023$85.70M+591.1%
Q2 FY2023Jun 30, 2023$26.30M+33.5%
Q1 FY2023Mar 31, 2023$50.20M-18.5%
Q4 FY2022Dec 31, 2022-$15.50M-376.8%
Q3 FY2022Sep 30, 2022$12.40M–
Q2 FY2022Jun 30, 2022$19.70M–
Q1 FY2022Mar 31, 2022$61.60M+72.5%
Q4 FY2021Dec 31, 2021$5.60M–
Q3 FY2021Sep 30, 2021-$600.00K-103.2%
Q2 FY2021Jun 30, 2021-$11.20M-106.4%
Q1 FY2021Mar 31, 2021$35.70M+105.2%
Q4 FY2020Dec 31, 2020-$6.20M-410.0%
Q3 FY2020Sep 30, 2020$19.00M-50.6%
Q2 FY2020Jun 30, 2020$173.80M+2494.0%
Q1 FY2020Mar 31, 2020$17.40M+100.0%
Q4 FY2019Dec 31, 2019$2.00M-93.8%
Q3 FY2019Sep 30, 2019$38.50M+104.8%
Q2 FY2019Jun 30, 2019$6.70M-80.1%
Q1 FY2019Mar 31, 2019$8.70M-56.5%
Q4 FY2018Dec 31, 2018$32.30M+151.4%
Q3 FY2018Sep 30, 2018$18.80M-34.1%
Q2 FY2018Jun 30, 2018$33.70M+55.7%
Q1 FY2018Mar 31, 2018$20.00M+85.2%
Q2 FY2017Jun 30, 2017$12.85M–
Q1 FY2017Mar 31, 2017$28.52M–
Q4 FY2016Dec 31, 2016$21.64M–
Q3 FY2016Sep 30, 2016$10.80M–

More Surgery Partners figures

See a number that looks wrong?